Table 1.
Baseline patient characteristics, mean + SD (n = 352)
Gleason 3+3 | Gleason 3+4 | p | |
---|---|---|---|
|
|||
No. patients | 268 | 84 | |
Age, years | 64 (7.4) | 64 (7.1) | - |
PSA, ng/ml median (IQR) | 4.9 (2.8–6.6) | 6.0 (4.4–8.8) | 0.762 |
Prostate Volume, cc | 52.0 (24.0) | 60.0 (21.0) | 0.001 |
PSA Density, ng/ml/cc | 0.108 (0.078) | 0.164 (0.109) | 0.009 |
Ethnicity | |||
Caucasian | 209 (77.6%) | 57 (67.9%) | 0.376 |
Hispanic | 12 (4.5%) | 7 (8.3%) | |
Asian American | 11 (4.1%) | 6 (7.1%) | |
African American | 11 (4.1%) | 4 (4.8%) | |
Not stated | 26 (9.7%) | 10 (11.9%) | |
Biopsy Data | |||
Max cancer core length, mm | 2.5 (2.1) | 3.7 (2.1) | 0.001 |
No. of cores | 15 (2.6) | 15 (3.2) | 0.977 |
No. of positive cores | 1.9 (1.4) | 2.4 (1.3) | 0.003 |